Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity-Reference-Cited by-同舟云学术

Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity

Published:2011-03-22 Issue:7 Volume:108 Page:1119-1123
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Kamat Ashish M.,Karam Jose A.,Grossman H. Barton,Kader A. Karim,Munsell Mark,Dinney Colin P.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.10026.x/fullpdf

Reference19 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2009

2. Bladder cancer;Kaufman;Lancet,2009

3. Natural history and treatment of low and high risk superficial bladder tumors;Rubben;J Urol,1988

4. Biology and management of bladder cancer;Raghavan;N Engl J Med,1990

5. Horner MJ Krapcho M Neyman N et al SEER cancer statistics review, 1975-2006, national cancer institute http://www.seer.cancer.gov/csr/1975_2006/results_merged/sect_27_urinary_bladder.pdf

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of URO17® in diagnosis and follow up of bladder cancer patients;BMC Urology;2024-02-09

2. BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study;Urologic Oncology: Seminars and Original Investigations;2023-12

3. Molecular Screening for Urothelial Cancer: How Close We Are?;Global Medical Genetics;2023-05-23

4. Microscopic hematuria and pelvic ultrasonography could rule out flexible cystoscopy during surveillance for T1-low grade non-muscle invasive bladder cancer;Arab Journal of Urology;2023-04-17

5. Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle‐invasive bladder cancer;Cancer Medicine;2023-03-25